-transparent.png){kind=logo}
Luteinizing hormone releasing hormone (LHRH), 100 mug, was administered to 60 patients with secondary amenorrhea. No side effects or adverse reactions occurred. Delayed FSH and LH peak outputs were observed in patients receiving LHRH subcutaneously rather than intravenously, but responses were otherwise comparable. The majority of patients with secondary amenorrhea had responses which fell into the 95% confidence limits of responses for normal ovulating women. Responses of patients with different forms of dysfunction may be similar, and patients with similar pathology may respond quite differently. The LHRH stimulation test may assist in the diagnosis of particular hypothalamic, pituitary, or gonadal dysfunction, but it must be used clinically in the context of a carefully integrated study.
A C Wentz, and
G S Jones, and
L Rocco, and
R R Matthews
May 1977,
Fertility and sterility,
A C Wentz, and
G S Jones, and
L Rocco, and
R R Matthews
December 1978,
Fertility and sterility,
A C Wentz, and
G S Jones, and
L Rocco, and
R R Matthews
June 1979,
American journal of obstetrics and gynecology,
A C Wentz, and
G S Jones, and
L Rocco, and
R R Matthews
October 2004,
Veterinary and human toxicology,
A C Wentz, and
G S Jones, and
L Rocco, and
R R Matthews
November 1972,
The New England journal of medicine,
A C Wentz, and
G S Jones, and
L Rocco, and
R R Matthews
March 1987,
American journal of obstetrics and gynecology,
A C Wentz, and
G S Jones, and
L Rocco, and
R R Matthews
January 1982,
Progress in clinical and biological research,
A C Wentz, and
G S Jones, and
L Rocco, and
R R Matthews
January 1973,
Gynakologische Rundschau,
A C Wentz, and
G S Jones, and
L Rocco, and
R R Matthews
June 1974,
The Journal of clinical endocrinology and metabolism,
A C Wentz, and
G S Jones, and
L Rocco, and
R R Matthews
October 1974,
American journal of obstetrics and gynecology,
